These are people who restrict severely, carry intense fear of weight gain, and meet every psychological criterion for anorexia nervosa, but whose body weight falls in a range that GLP-1 prescribers may read as an indication for treatment
[5] While GLP-1 receptor agonists should not be prescribed solely for cholesterol lowering, certain patient populations may derive particular benefit from their lipid and broader cardiometabolic effects
Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials
Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre- and post-treatment study
This study was thorough and clinically run, but after measuring six major cognitive performance aspects (executive function, attention and focus, inspiration, perceived stress, work engagement, and mindfulness) as well as self-reported sleep quality, immune health, productivity, and mood, researchers found that there was little difference between Qualia Mind and a placebo